Impact Partnership Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.48M Buy
3,004
+558
+23% +$658K 0.31% 43
2026
Q2
$2.93M Buy
2,446
+120
+5% +$123K 0.29% 42
2026
Q1
$2.14M Buy
2,326
+483
+26% +$490K 0.26% 50
2025
Q4
$1.98M Buy
1,843
+1,546
+521% +$1.48M 0.25% 39
2025
Q3
$227K Buy
297
+32
+12% +$23.8K 0.03% 273
2025
Q2
$207K Sell
265
-595
-69% -$462K 0.04% 273
2025
Q1
$710K Sell
860
-162
-16% -$135K 0.15% 74
2024
Q4
$789K Buy
1,022
+305
+43% +$253K 0.16% 78
2024
Q3
$635K Sell
717
-164
-19% -$147K 0.14% 90
2024
Q2
$798K Buy
881
+422
+92% +$338K 0.21% 61
2024
Q1
$357K Buy
459
+456
+15,200% +$325K 0.14% 104
2023
Q4
$1.75K Sell
3
-198
-99% -$116K ﹤0.01% 711
2023
Q3
$108K Sell
201
-92
-31% -$47.4K 0.03% 306
2023
Q2
$137K Buy
+293
New +$123K 0.05% 165

Other funds holding LLY

Impact Partnership Wealth's LLY Position: Q3 2026 in Review

Impact Partnership Wealth increased its Eli Lilly (LLY) stake by 23% in Q3 2026, buying an estimated $658K and bringing the position to 3,004 shares worth $3.48M. The position accounts for 0.31% of the portfolio, ranked #43.

Impact Partnership Wealth first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. 4,303 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Impact Partnership Wealth held 3,004 shares of Eli Lilly worth $3.48M as of Q3 2026.
  • Impact Partnership Wealth bought 558 Eli Lilly shares in Q3 2026, an estimated $658K.
  • Eli Lilly made up 0.31% of Impact Partnership Wealth's portfolio in Q3 2026, its #43 holding.
  • Impact Partnership Wealth first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
  • 4,303 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Impact Partnership Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.